Couverture de Let's talk F*ng Cancer

Let's talk F*ng Cancer

Let's talk F*ng Cancer

De : Colette Hoang
Écouter gratuitement

3 mois pour 0,99 €/mois Offre valable jusqu'au 12 décembre 2025. 3 mois pour 0,99 €/mois, puis 9,95 €/mois. Offre soumise à conditions.J'en profite

À propos de ce contenu audio

Welcome to the Let's Talk F*ng Cancer podcast. Where we will be covering all things in the cancer world. With our 4 monthly topics covering professionals from the cancer world, tips& tricks to get through your chemotherapy, radiation and more. We will also be having spotlight episodes speaking with cancer survivors and thrivers, as well as a grief and remembrance segment focusing on saying the names of loved ones passed.Copyright 2025 Colette Hoang Hygiène et vie saine Maladie et pathologies physiques Médecine alternative et complémentaire Psychologie Psychologie et psychiatrie
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Ep. 85 Cara Lockwood bestselling author and cancer survivor
      Oct 28 2025

      When bestselling author Cara Lockwood was diagnosed with Stage 1 breast cancer in 2023, she didn’t look for inspiration in solemn pamphlets or dusty medical books. She looked for laughter, swearing, and straight talk — the kind of encouragement you get from your funniest, most unfiltered friend. In "There’s No Good Book for This but I Wrote One Anyway: The Irreverent Guide to Crushing Breast Cancer" (Oct. 1, 2025), Cara shares the gritty, absurd, and often hilarious truth about treatment, recovery, and life after a double mastectomy, chemo, and reconstruction.

      Part Memoir. Part Pep Talk. Part Screaming Into the Void.

      For Patients, Survivors, and the People Who Love Them

      Laugh, Cry, and Then Laugh Again

      Fighting for a Cure — One Book at a Time

      Get your copy Below:

      https://caratanamachi.com/no-good-book-for-this

      https://caratheauthor.com/

      Find Cara on Social Media

      https://www.instagram.com/cara.the.author/

      https://www.facebook.com/AuthorCaraLockwood/

      https://www.linkedin.com/in/cara-lockwood-563b5040/

      https://www.tiktok.com/@caratanamachi

      Afficher plus Afficher moins
      53 min
    • Ep. 84 - "Whats New In Cancer News and Research" September Childhood cancer, Blood cancer, Thyroid cancer, Ovarian and Gynecological cancers
      Oct 1 2025

      🌟 September is HUGE for cancer awareness 🌟

      This month shines the spotlight on:

      🩸 Blood cancers

      🎗️ Childhood cancer

      🌸 Gynecologic & ovarian cancers

      👨 Prostate cancer

      🦋 Thyroid cancer

      In my latest What’s New solo episode, I’m diving into:

      ✅ Breakthrough drugs giving blood cancer patients longer remissions

      ✅ A 12-year-old’s inspiring story of targeted therapy success

      ✅ CAR-T therapies expanding into ovarian cancer

      ✅ New prostate cancer screening guidelines

      ✅ The rise of precision medicine & theranostics

      ✅ Futuristic innovations like synthetic drug factories inside the body 🤯

      💪 Research is moving fast, and awareness saves lives. Tune in to learn, get inspired, and spread the hope.#LetsTalkFnCancer #CancerAwarenessMonth #CancerResearch #Podcast #CancerBreakthroughs

      sources:

      Highlights in this episode:
      • Blood cancers: Eli Lilly’s Jaypirca helps CLL/SLL patients live longer without progression; CAR-T therapy delivers remission for aggressive lymphoma 【web†source】.
      • Childhood cancer: A 12-year-old’s brain tumor stabilized after a targeted melanoma drug via the ZERO program in Sydney 【web†source】.
      • Gynecologic & ovarian cancers: CAR-T therapy expands into solid tumors; Eli-002 cancer vaccine shows strong KRAS-targeted immune responses 【web†source】.
      • Prostate cancer: Proposed guidelines could lower PSA screening age to 40, paired with MRI for more precise detection 【web†source】.
      • Thyroid cancer: Theranostics—blending diagnostics and therapy—emerges as a precision medicine frontier 【web†source】.
      • Broader innovations: New immunotherapies, remote clinical trials, synthetic drug factories, and research to prevent recurrence in breast cancer 【web†source】.

      Sources:
      • Reuters — Lilly’s blood cancer drug meets main goal in late-stage study
      • Daily Telegraph — 12-year-old Sydney boy’s inspiring brain tumour journey
      • Fraunhofer — CAR-T cells fight solid tumors
      • New York Post — Cancer vaccine may prevent recurrence of pancreatic/colorectal tumors
      • The Australian — Prostate cancer guideline update
      • Wikipedia — Theranostics overview
      • Reuters — BioNTech/Bristol Myers immunotherapy trial
      • Cure Today — New clinical trials launch as cancer studies advance
      • The Times —
      Afficher plus Afficher moins
      28 min
    • Ep. 83 - Spotlight: Anne, Triple Positive Breast Cancer, a journey of Nerve Blocks a Divorce, Curling and 5 yrs CANCER FREE
      Sep 2 2025

      🌟 Spotlight Episode: Anne’s Story 🌟

      This week on Let’s Talk Fng Cancer*, we spotlight Anne — a triple positive breast cancer survivor with an incredible story of strength and healing.

      Anne began her treatment right at the start of COVID, enduring her diagnosis during one of the most isolating times imaginable. After completing treatment, she faced another life-altering challenge: a divorce.

      Through it all, Anne found her path forward. She embraced therapy, focused on her health, and — during recovery — discovered the sport of curling, which gave her both joy and community. Today, she’s standing stronger than ever, with a powerful message about resilience and rebuilding life after cancer.

      Her journey shows us that survivorship is about more than getting through treatment — it’s about finding new strength, purpose, and connection. 💪✨

      Kaiser, Dr Bodai- Cancer Recovery and Survivorship

      Afficher plus Afficher moins
      1 h et 33 min
    Aucun commentaire pour le moment